Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.

Item
http://www.wikidata.org/entity/Q35552216
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective studyEfficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.Anti-TNF-alpha therapy in ankylosing spondylitis.Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.Infliximab for the treatment of ankylosing spondylitis.Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides.Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.Infliximab in the treatment of ankylosing spondylitis.Anti-TNF-alpha therapy with infliximab in spondyloarthritides.Management of ankylosing spondylitis with infliximab.Evaluation of sleep quality in patients with ankylosing spondylitis and efficacy of anti-TNF-α therapy on sleep problems: A polisomnographic study.The relationship between C-reactive protein rs3091244 polymorphism and ankylosing spondylitis.
P2860

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.

Item
http://www.wikidata.org/entity/Q35552216
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@ast
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@en
type
label
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@ast
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@en
prefLabel
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@ast
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932